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Carbon nanotube-based biomaterials critically contribute to the design of many prosthetic devices, with a particular impact in the
development of bioelectronics components for novel neural interfaces. These nanomaterials combine excellent physical and chemical
properties with peculiar nanostructured topography, thought to be crucial to their integration with neural tissue as long-term implants. The
junction between carbon nanotubes and neural tissue can be particularly worthy of scientific attention and has been reported to significantly
impact synapse construction in cultured neuronal networks. In this framework, the interaction of 2D carbon nanotube platforms with
biological membranes is of paramount importance. Here we study carbon nanotube ability to interfere with lipid membrane structure and
dynamics in cultured hippocampal neurons. While excluding that carbon nanotubes alter the homeostasis of neuronal membrane lipids, in
particular cholesterol, we document in aged cultures an unprecedented functional integration between carbon nanotubes and the
physiological maturation of the synaptic circuits.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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Neurons are continuously exposed to signals generated by the decorate bio-interfaces with nano-features5,6 and incorporating
extracellular environment, including genuine physical cues (such
as mechanical or topographical ones) at the nanoscale, able to
drive key biological tasks.1 This ability has been exploited to
engineer interfaces with nanostructures with the aim of guiding
nerve tissue re-growth.2–4 Varied strategies have been adopted toAbbreviations: AFM, atomic force microscopy; CT-B, Cholera Toxin subun
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when artificially reconstructed by multi-walled carbon nanotubes
(MWCNTs), induced synaptogenesis in cultured hippocampal
neurons during early network formation.12,15,16 Enhancing
cell-to-cell communication is crucial in neural circuits'
settings,17 however the role and dynamics of the interactions
between MWCNTs and the cellular surfaces (the “nano-bio”
interface18) are largely unexplored.
The majority of current studies on biological membrane
stability in response to nanomaterials are focused on the
influence of materials' functionalization or shape/size on cell
uptake mechanisms and internalization, to engineer sophisticated
drug delivery (nano)-vectors.19 In this framework, neuronal
membranes have been shown to recover even when transiently
pierced or deformed by (nano)needles20 or other intracellular
(nano) delivery systems.21 Water-soluble single-walled carbon
nanotubes grafted to poly ethylene glycol impaired, when added
to the culturing medium, membrane re-cycling in neurons,
presumably by affecting the endocytosis of released vesicles at
the pre-synaptic site.22 However, more specific information
about neuronal membrane stability when chronically interfaced
to pristine nanomaterial-based growth substrates is lacking. Cell
membranes are directly exposed to MWCNTs,14,23 but there are
no reports on the effects that MWCNT interfaces exert on
neuronal membrane equilibrium. Recent studies targeted the
interaction between lipoid membranes and MWCNTs in
suspension.24,25 Molecular simulations showed that significant
changes in the structure of individual lipid molecules, and in
their two-dimensional packing, were observed when MWCNTs
were adsorbed on cell membranes and subsequently pierced the
lipid bilayer.26,27
Here, by single cell electrophysiology and immunofluores-
cence microscopy we monitor the dynamics of glutamate
receptor-mediated excitatory transmission in cultured hippocam-
pal neurons interfaced to MWCNTs. We specifically addressed
whether MWCNTs, once interfaced to neurons, affected synaptic
transmission by modulating lipid membrane structure and
dynamics. We focused in particular on cholesterol, a largely
represented lipid in neuronal membranes known to regulate
presynaptic vesicle release.28,29 For a first general assessment we
used artificial lipid membranes that, when interfaced to
MWCNTs, were more stable, in respect to controls, to a
cholesterol depleting-agent, i.e. cyclodextrin.30 Conversely, in
cultured neurons, MWCNT interfaces did not alter the membrane
cholesterol distribution neither prevented its subsequent deple-
tion by cyclodextrin. Unexpectedly, by cholesterol removal, we
unmasked MWCNT ability to shape pre-synaptic vesicle
populations at newly formed glutamatergic connections. Finally,
we followed up the effects of long term MWCNT interfacing in
neural synaptic networks.Methods
Synthesis of MWCNTs
MWCNTs 20-30 nm in diameter (Nanostructured &
Amorphous Materials, Inc.) were used as received and substrates
were prepared as described previously.12,15 Briefly, MWCNT20-30 nm were functionalized using 1,3-dipolar cycloaddition
with heptanal and sarcosine at 130 °C for 120 h in dimethylfor-
mammide (DMF) as solvent. For deposition on the coverslips,
the DMF solution of functionalized MWCNTs (0.01 mg/mL)
was drop casted to uniformly layer the entire substrate and let
evaporated at 80 °C, then, the substrates were heated up at
350 °C under N2 atmosphere to induce the complete
re-pristinization of MWCNTs. The uniformity of the deposition
was assumed by AFM (Figure 1, B) and by scanning electron
microscopy (SEM, in Supplementary Figure S1, D).
Artificial membrane preparation and characterization
Artificial membranes were prepared by lipid spreading on a
supporting glass slide from an organic solvent solution.
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) and choles-
terol molecules (both from Avanti Polar Lipids Inc., US) were
dissolved in a 2:1 ratio in chloroform (Sigma Aldrich) at a final
concentration of 100 μM. 100 μL of solution were deposited on
a glass coverslip, used as control, and on MWCNTs substrates
supported by the same glass coverslip (Figure 1).15 Samples
were settled at 37 °C, 80% UR for 30 min, then rinsed in mQ
water, dried with a gentle flow of N2 and mounted on metallic
plates using epoxy glue for subsequent atomic force microscopy
(AFM) imaging (MFP-3D™, Asylum Research, Santa Barbara,
CA, U.S.). Measurements were carried out in buffer solution
(HEPES, Sigma Aldrich) at room temperature (RT, 18 to 22 °C)
working in dynamic mode. Cantilevers, characterized by a
resonant frequency of 69 kHz and force constant of 0.39 nN/nm
(OMCL-RC800PSA-1 tips from Olympus Co., Japan), were
used working at low oscillation amplitudes with half
free-amplitude set-point. Images were acquired at 512 × 512
pixels at 0.75 lines/s scan speed. Artificial membranes for
fluorescence experiments were prepared following the same
procedure described above but DOPC molecules were mixed
with 2% of fluorescent lipid (18:1-06:0 NBD PC, from Avanti
Polar Lipids Inc., US). Fluorescent measurements were done by
epifluorescence microscopy (Eclipse Ti-U, Nikon Co., Japan;
20× objective, 0.45 NA). Samples were mounted in a liquid cell
and the decay in fluorescent signal from both membranes
deposited on control and MWCNT substrates were recorded for
60 min after injection of 500 μM Methyl-β-Cyclodextrin
(MβCD, Sigma Aldrich) to deplete cholesterol.30 Decay plots
are the average of 3 independent experiments. Values were
normalized to the fluorescent signal immediately before MβCD
injection. AFM images were analyzed using Gwyddion,
open-source modular program for scanning probe microscopy
(SPM) data visualization and analysis.31 Surface roughness
was determined as RMS value of the height irregularities on
2.5 μm2 membrane area. Decays were fitted using a double
exponential function using Igor Pro software (Wavemetrics,
US). Figure S1, C shows the amplitude (error) AFM images of
the high magnification reconstructions shown in Figure 1,
A-C.
Raman characterization
The Raman measurements were performed in the reflection
geometry. A 532 nm continuous-wave laser (Cobolt Samba,
Figure 1. AFM investigation of artificial lipid membranes (SLM). (A) Low magnification topographic reconstruction of an incomplete SLM deposited on a
control glass surface (on the top). The height profile corresponding to the highlighted line is shown, revealing SLM height of about 5.0 ± 0.2 nm. Higher
resolution AFM reconstruction (on the bottom) demonstrates the high uniformity of the so obtained SLB. B. Low magnification topographic reconstruction,
corresponding height profile and higher resolution reconstruction of a MWCNTs carpet deposited on glass via drop-casting. Note the high corrugation of the
resulting surface pointed out by the top image and single MWCNTs composing the carpet easily distinguishable in the bottom one. (C) Low magnification
topographic reconstruction, corresponding height profile and higher resolution reconstruction of SLBs deposited on a MWCNTs substrate. It is possible to
appreciate (white arrows) MWCNT ability to pierce SLMs, indicated by nanotubes emerging from the upper membrane layer. The altimetric profile reveals flat
parts, corresponding to superficial SLBs, from which onlyMWCNTs apexes protrude. (D) Fluorescent decay of SLMs signal after injection of MβCD (500 μM)
detected in control (squares) and on MWCNT (circles) membranes. Note that the decay follows a double exponential law characterized by τ values of 1.09 ± 0.02 s
and 39.02 ± 9.83 s (gray fitting line) for SLM deposited on glass and 2.02 ± 0.15 s and 63.67 ± 6.92 s for SLM deposited on the MWCNT carpet (black fitting line).
Data are averages of 3 independent experiments expressed as mean ± SD. Initial values were normalized before injection of MβCD. E. Raman spectra acquired in the
highlighted areas (colored dots) in the bottompanels ofA, B and C (glass substrate in yellow, SLM on glass in orange, MWCNTs on glass in green and SLM above
MWCNTs in blue). Note that the spectra ofMWCNTswith (blue spectrum) andwithout (green spectrum) SLMswere vertically shifted for illustrative purpose.
The reference spectrum of lipids (red spectrum) was acquired on amany-layer membranes sample (MLMs, not shown) in order to minimize Raman signal from
the underlying glass surface.
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beam was focused on the sample by a 100× air objective (NA
0.8, EC EpiPlan, Zeiss) resulting in a diameter of laser spot of
about 0.5 μm. A 532 nm RazorEdge Dichroic™ laser-flat
beam-splitter and a 532 nm RazorEdge® ultra-steep long-pass
edge filter were used to direct the light into microscope and cut
Rayleigh scattered light, respectively. The laser power on the
sample was controlled by the neutral density filter (Thorlabs) and
kept at 100 μW. The acquisition time in all experiments was
60 s. All Raman measurements and analysis were performed by
CNR-IOM (TASC Laboratory, Basovizza, Trieste, Italy).
Primary cultures and cell treatment
Hippocampal neurons were obtained from neonatal rats as
previously reported. 15 Cells were plated on poly-L-
ornithine-coated (Sigma Aldrich) or on MWCNT-coated glass
coverslips and incubated at 37 °C, 5% CO2 in culture medium.
Cultured cells were used for experiments either at 8 to 10 and 18
to 21 days in vitro (DIV). To deplete cholesterol from neuronal
membranes, cultures were incubated with 1 mM MβCD (Sigma
Aldrich) for 1 h at 37 °C.30 MβCD is a cyclic glucose oligomerwith a hydrophobic cavity that is able to bind lipids (especially
cholesterol) and make them water-soluble32 and is commonly
used to deplete membrane cholesterol acutely from both leaflets
of the bilayer.33
Electrophysiology
Patch-clamp, whole cell recordings were obtained with glass
micropipettes with a resistance of 4 to 8 MΩ. The intracellular
pipette solution was the following (mM): 120 K gluconate, 20
KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP, pH 7.3. The
external standard saline solution contained (mM): 150 NaCl, 4
KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, 10 glucose, pH 7.4. All
recordings were performed at RT. Cells were voltage clamped at
a holding potential set at −56 mV (not corrected for the liquid
junction potential, calculated to be 13.7 mV at 20 °C). The
uncompensated series resistance had values b8 MΩ. Miniature
post-synaptic currents (mPSCs) were recorded in the presence of
1 μM fast-Na+ channel blocker Tetrodotoxin (TTX; Latoxan). In
order to block voltage-gated calcium channels we added 3 mM
CoCl2 to the external solution. Data were collected using a
Multiclamp 700A Amplifier (Molecular Devices, US), and
Figure 2. Cholesterol removal by MβCD application in hippocampal cultures. (A) Representative traces of spontaneous synaptic activity in control (left) and
MWCNT (right) neurons before (top) and after (bottom) MβCD application. (B) Box plots summarize pooled data of PSC frequencies (top) and amplitudes
(bottom) recorded from control and MWCNTs neurons prior and after MβCD. Note the higher PSC frequency displayed by MWCNT neurons in standard saline
and the opposite effects brought about by MβCD in control and MWCNTs.
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Axograph (Axograph Scientific). Glutamate AMPA-receptor
and GABAA-receptor mediated post synaptic currents (PSCs)
were isolated offline by building two templates with different
kinetic parameters: respectively 0.1 ms rise-time; 3 and 30 ms
decay time constant (τ); 10 and 100 ms template length.
Previous work12,15indicated that in our experimental conditions,
the vast majority of fast-decaying (τ b 5 ms) PSCs are mediated
by the glutamate AMPA-receptor type; while the slow-decaying
(τ N 20 ms) PSCs are mediated by the GABAA-receptor type.
Immunocytochemistry
Cultures were fixed in 4% formaldehyde (prepared from fresh
paraformaldehyde) in PBS for 20 min, permeabilized with 0.3%
Triton-X-100 and subsequently incubated with primary antibod-
ies for 30 min at RT and after washing in PBS incubated with
secondary antibodies for 45 min. Cultures were then mounted
with the Vectashield (Vector Laboratories) on 1 mm thick
microscope glass slides. To visualize neurons and lipid rafts we
used the following: rabbit anti-β-tubulin III primary antibody
(Sigma T2200, 1:250 dilution) and Alexa 594 goat anti rabbit
secondary antibody (Invitrogen, 1:500); Alexa 488 Cholera
Toxin subunit-B (CT-B) 1:200 (Molecular Probes) and DAPI,
1:1000 (Invitrogen).
To visualize glutamatergic synapses we co-label neurons with
the guinea pig anti-vesicular glutamate transporter 1 (VGLUT1;
Millipore, 1:2000) and β-tubulin III (Sigma, 1:250) primary
antibodies and Alexa 594 goat anti rabbit (Invitrogen, 1:500) and
Alexa 488 goat anti guinea-pig (Invitrogen, 1:500) as secondary
antibodies. All images were acquired using an inverted confocalMicroscope (Leica Microsystems GmbH, Wetzlar, Germany;
40× oil immersion objective, 1.25 NA).
To quantify VGLUT1 puncta and lipid rafts, n = 20 ± 10
z-stacks (acquired every 0.4 μm) were taken from n = 10
randomly selected fields (240 μm × 240 μm) per coverslip
(n = 30, 3 culture series in Control and MWCNTs). To quantify
lipid rafts, we selected the CT-B positive objects (b5 μm3)
co-localized to the β-tubulin III positive areas. For each image,
the volumes of CT-B positive objects were normalized to the
β-tubulin III positive volumes. To quantify VGLUT1 puncta, we
selected only VGLUT1-positive puncta (b2 μm3) co-localized
to the β-tubulin III positive areas and puncta were normalized to
the β-tubulin III positive volumes. Images were analyzed using
the Volocity software (Perkin Elmer).
For the filipin labeling of membrane cholesterols34 cells were
fixed, rinsed in PBS and directly incubated for 2 h at RT with
0.05 mg/mL filipin (Sigm-F9765) then mounted and imaged
with an Epifluorescence Microscope (DM 6000, Leica; 40×
objective, 0.75 NA). We collected 10 fields (355 μm × 265 μm)
per coverslip (n = 30, 3 culture series for control and MWCNT)
with the same CCD exposure time and illumination intensity. For
each image the background fluorescence was subtracted and the
fluorescence of four equal squared areas was determined. The
average of these four values represented the fluorescence
intensity value for each image.34 Fluorescence signals were
quantified using ImageJ software (http://rsb.info.nih.gov/ij/).
Data analysis
All values from samples subjected to the same experimental
protocols were pooled together and expressed as mean ± SEM
Figure 3. MβCD efficiently removed membrane cholesterol without disrupting lipid rafts. (A) Fluorescence micrographs of control and MWCNT hippocampal
cells labeled by filipin prior (top) and after (bottom) MβCD treatment. Scale bars 50 μm. (B) Bar plot of filipin-derived fluorescence intensity in cultured
neurons, note the similar values between control and MWCNT conditions and the comparable reduction upon cholesterol depletion by MβCD. (C) Left, 3D and
2D confocal reconstructions of hippocampal cultures immune-labeled with the neuronal marker β-tubulin III (in red) and the lipid-raft marker CT-B (in green), in
blue DAPI labeling for nuclei. Scale bars 15 μm. Right, bar plot quantifies the CT-B volume in respect to the β-tubulin III one, note that no differences were
observed between controls and MWCNTs before and after the MβCD treatment.
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statistically significant difference between data sets was assessed
by one-way and two-way ANOVA, followed by Bonferroni test.
Statistical significance was determined at P b 0.05, unless
otherwise indicated. Box plots were created using Plotly
software (https://plot.ly).
Ethical statement
All animal procedures were conducted in accordance with the
National Institutes of Health and with international and
institutional standards for the care and use of animals in
research, and after consulting with a veterinarian. All experi-
ments were performed in accordance with European Union (EU)
guidelines (2010/63/UE) and Italian law (decree 26/14) and were
approved by the local authority veterinary service and by our
institutional (SISSA-ISAS) ethical committee. All efforts to
minimize animal suffering and to reduce the number of animals
used were made. Animal use was approved by the ItalianMinistry of Health, in agreement with the EU Recommendation
2007/526/CE (http://eur-lex.europa.eu/legal-content/EN/TXT/
?uri=uriserv:OJ.L_.2007.197.01.0001.01.ENG&toc=
OJ:L:2007:197:TOC).Results
Artificial lipid membranes interfaced to MWCNTs
In the first set of experiments, we investigated by AFM the
appearance of artificial lipid membranes (SLM)35 interfaced to
control substrates or to MWCNTs (Figure 1, B; see also15). SLM
islands grown on control glass coverslips (Figure 1, A) and on
MWCNTs (Figure 1, C) displayed similar morphology (SLM
surface roughness 0.38 nm and 0.44 nm when formed on glass
and on MWCNT, respectively, Figure 1, A-C), however AFM
revealed the ability of MWCNTs to pierce membrane layers
through SLM entire thickness (Figure 1, C, white arrows). These
cross interactions induced the occasional appearance of localized
Figure 4. Depletion of cholesterol with MβCD alters fast PSCs occurrence. (A) Offline differential analysis of PSC decays (τ) identifies fast and slow events
(insets average tracings from the same neurons as in Figure 2, A) both in control and MWCNTs. Bar plot summarizes the frequency of fast and slow PSCs in
controls and MWCNTs. (B) Spontaneous synaptic activity recorded in the presence of TTX; controls and MWCNT mPSC frequency and amplitudes are
summarized in the box plots before and after MβCD treatment. Note that mPSC amplitude values are unaffected.
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MWCNTs, a condition rarely observed in controls (Figure 1, A
and C, compare the height profiles).
In Figure 1, E the reference Raman spectrum of lipids (in red)
is plotted and is characterized by peaks associated with C–N
stretch (715 cm−1), C–C stretch (1090 cm−1), CH2 deformation
(1305 cm−1 and 1440 cm−1), and C = C stretch (1655 cm−1)
vibrations.36,37 The Raman spectrum of MWCNTs alone on
glass substrate (Figure 1, E, in green) shows two broad peaks
centered at 1350 cm−1 and 1590 cm−1 that are commonly
assigned to the presence of disorder in graphitic materials and to
the tangential vibrations of the carbon atoms, respectively.38,39
The dis t inguishable shoulder a t 1620 cm −1 is a
double-resonance Raman feature induced by disorder, defects
or ion intercalation between the graphitic walls.38 When SLMs
are deposited on glass substrate (Figure 1, E, in orange), the
strong contribution of the underneath glass is evident, however
the lipid peak at 1440 cm−1 (CH2 deformation) is distinguish-
able in spite of the lower amount of lipids forming the SLM. In
SLM on MWCNTs, the characteristic two peaks at 1350 cm−1
and 1590 cm−1 present on the tubular structures protruding from
SLMs (depicted in Figure 1, C, bottom panel) confirm that they
are MWCNTs, as suggested by the AFM morphology.
Interestingly, in this spectrum (in blue in Figure 1, E), the peak
at 715 cm−1 is evident as well. This may be due to the larger
laser spot diameter (about 500 nm) compared with MWCNTs
(50-250 nm), resulting in a contribution of the surrounding SLBs
in the Raman spectrum. Note that broad peaks observed at400 cm−1 and 900 cm−1 are due to a photoluminescence in glass
substrate, a well-known phenomenon when using a 532 nm
excitation wavelength.40
Next, we incorporated a fluorescent lipid to SLMs (see
Methods) and we compared the efficacy of MβCD treatment
(500 μM; 1 h; used to bind and extract cholesterol from the
membrane32,33) in depleting cholesterol in control and MWCNT
SLMs. The plot in Figure 1, D summarizes the decay in
fluorescence monitored during MβCD application. In order to
have comparable measurements, we sampled single SLM layers
in both groups. In MWCNTs, SLM lipids appeared more
stabilized, as indicated by their significantly slower depletion
with respect to controls (decay time constant (τ) average values:
τ1 = 1.09 ± 0.02 s and τ2 = 39.02 ± 9.83 s for control SLMs;
τ1 = 12.02 ± 0.15 s and τ2 = 63.67 ± 6.92 s for SLM deposited
on MWCNTs; P b 0.01 for τ1 values; P b 0.05 for τ2; n = 3
different samples each group).
Such results suggest that interfacing with MWCNTs might
affect lipid, in particular cholesterol, dynamics in biological
membranes.
Acute cholesterol removal in control and MWCNTs
hippocampal cultures
To further explore the potential role of MWCNTs in membrane
lipid dynamics when interfacing living cells, and in particular in
altering cholesterol homeostasis in neurons, we cultured hippo-
campal cells on control substrates or on meshworks of MWCNTs
Figure 5. Co-localization of VGLUT1 and β-tubulin III immunostaining in control and MWCNT hippocampal cultures. (A) Right, confocal images of
hippocampal neurons at 8-10 DIV stained for β-tubulin III (in red) and VGLUT1 (in green). In the insets high magnifications are shown corresponding to the
white square areas. Scale bars 20 μm. Left, bar plot summarizes the quantification of VGLUT1 positive puncta, significantly higher in MWCNTs. (B) Right,
summary graph of the PSCs frequency in standard saline solution and after TTX and Co++ application in controls (squares) and MWCNTs (circles). Right, bar
plot summarizes the residual activity, in respect to standard saline, after application of TTX and Co++.
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networks before and after cell exposure to MβCD (1 mM; 1 h)30
by voltage clamp whole-cell recordings, comparing Control
neurons with MWCNT ones. The first set of recordings was
performed at 8-10 DIV, since at this ages neuronal circuits were
reported to display a significant increase in synaptic activity when
cultured on MWCNTs.12,14,15Figure 2 illustrates this characteris-
tic enhancement in spontaneous synaptic activity brought about by
MWCNTs and expressed as a significant (P b 0.05) increase (by
133%) in the post synaptic current (PSC) frequency (box plot in
Figure 2, B, top; control, n = 22; MWCNT, n = 21), leaving PSC
amplitudes unperturbed (box plot in Figure 2, B, bottom).12,14,15
Sample tracings of control and MWCNT recordings are shown in
Figure 2, A (top row).
Exposure to MβCD did not affect neuronal viability and the
overall integrity of membranes as estimated by comparing the
input resistance values of the recorded neurons before and after
treatment (for control: 655 ± 73 MΩ, n = 21, and 694 ±
167 MΩ, n = 23, P = 0.834; for MWCNT 487 ± 37 MΩ, n =
22, and 625 ± 90 MΩ, n = 23, P = 0.117; prior and after MβCD
incubation, respectively) and the values for the cell capacitance
(for control: 75 ± 32 pF, n = 21, and 80 ± 7 pF, n = 23, P =
0.536; for MWCNT 92 ± 8 pF, n = 22, and 74 ± 7 pF, n =
23,P = 0.120; prior and after MβCD incubation, respectively).
Synaptic cholesterol balances spontaneous and evoked
neurotransmission by inhibiting spontaneous vesicle turnover
and, conversely, by promoting evoked exo-endocytosis.28 In
hippocampal cultures, MβCD-mediated removal of cholesterol
has been reported to result in an augmentation of spontaneous
synaptic vesicle fusion and recycling.28
We measured synaptic activity in these two groups of cultures
after cholesterol depletion and, surprisingly, addition of MβCD
resulted in two macroscopic, but opposite, changes, illustrated by
the sample recordings in Figure 2, A (bottom tracings). In control
neurons MβCD treatment led to a significant (P b 0.01) increase
(by 228%) in PSC frequency, without affecting PSC amplitude
values; in MWCNTs, on the contrary, MβCD incubation
induced a significant reduction in both PSC frequency (by
62%; P b 0.05) and PSC amplitude (by 55% P b 0.01;
summarized in the box plots of Figure 2, B). Before analyzingin more details these synaptic changes (see below) we ascertain
whether the tight interfacing14 of neuronal membrane with
MWCNTs modulated membrane cholesterol in cultured neurons.
Figure 3, A shows sample micrographs of cultured neurons
(control and MWCNTs) labeled with filipin, used to detect free
cholesterol.41 Cholesterol levels, as measured by filipin
fluorescence intensity (see Methods) were similar in the two
culture groups (summarized in Figure 3, A and B). MβCD
incubation efficiently removed membrane cholesterol in both
culture groups, as documented by the drop in filipin fluorescence
intensity after treatments (reduced by 44% in controls and by
52%, in MWCNT, quantified in Figure 3, B; n = 30 fields in
control and MWCNTs). We further explored the ability of
MβCD incubation in altering, in the two neuronal cultures, the
integrity of cholesterol/sphingolipid micro-domains (i.e. lipid
rafts), expressed by cultured hippocampal neurons.42 We
visualized lipid rafts by double labeling neurons with the raft
marker CT-B43 and the neuronal marker β-tubulin III (Figure 3,
C). We calculated by confocal analysis the CT-B volume relative
to the β-tubulin III one (see Methods) to quantify lipid rafts
before and after MβCD incubation. In Figure 3, C the bar plot
shows the comparable values of the CT-B/β-tubulin III volumes
in the two cultures groups, and that apparently MβCD treatment
did not deplete CT-B domains in control and MWCNTs. Thus,
the used incubation protocol for cholesterol depletion efficiently
reduces free cholesterol from neuronal membranes in both
cultures, without affecting the integrity of cholesterol-enriched
structures, such as lipid rafts.
Despite the similar effects with respect to cholesterol,
MβCD affects in an opposite manner PSCs frequency in control
and MWCNTs, suggesting the presence of presynaptic
terminals where vesicle release is differentially regulated by
cholesterol.44
Effects of acute cholesterol depletion on glutamatergic
synapses
Spontaneous synaptic activity in our recording conditions15
was manifested as inward currents made up by a mixed
population of inhibitory (GABAA-receptor mediated) and
Figure 6. Controls and MWCNTs spontaneous synaptic activity in long-term cultures. (A) Left, representative recordings of synaptic activity at 21 DIV in
controls and MWCNTs before (top) and after (bottom) MβCD. Box plots (right) summarize the values of PSCs frequency (top) and amplitude (bottom); note the
similar values measured in all conditions. (B) Confocal micrographs of cultures labeled by β-tubulin III (in red) and VGLUT1 (in green). In the insets high
magnifications are shown corresponding to the white square areas. In long-term cultures controls and MWCNTs neurons display similar amount of VGLUT1
puncta, summarized in the bar plot (right). Scale bar, 20 μm.
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terized by different kinetics.15 To gain insights into the MβCD
regulation of synaptic activity in the two culture groups, we
randomly selected a subset of control (n = 7) and MWCNT (n =
7) neurons to perform offline differential analysis of PSCs
kinetic, in particular of their decay.12,45 By means of their kinetic
properties we identified slow decaying PSCs (τ = 22.0 ± 2.0 ms
in control; τ = 21.2 ± 1.1 ms in MWCNTs; Figure 4, A top
right) corresponding to GABAA receptor-mediated events from
fast decaying (τ = 3.1 ± 0.3 ms in control; τ = 3.4 ± 0.4 ms in
MWCNTs; Figure 4, A top left) events usually corresponding to
AMPA-receptor mediated currents.12,15 The frequency of fast
PSCs was upregulated by MβCD in control, but strongly
reduced in MWCNT exposed to similar treatments (plot in
Figure 4, A). Notably, slow PSC frequencies were similarly (and
only slightly) reduced in both culture groups when exposed to
MβCD.Cholesterol depletion in neurons is known to increase the rate
of spontaneous transmission but it impairs evoked
neurotransmission28,29 and synapses usually segregate, at the
presynaptic terminals, the distinct vesicle pools responsible for
spontaneous or evoked release.29,46
We characterized the effects of cholesterol depletion on
spontaneous release by recording miniature PSCs (mPSCs) in the
presence of TTX (1 μM). mPSCs, in dissociated hippocampal
cultures at this age, comprise virtually only fast events (τ =
4.5 ± 0.6 ms in control, n = 9, and τ = 5 ± 0.9 ms in MWCNT,
n = 9; Figure 4, B, top tracings) thus representing only excitatory
mPSCs.15 MWCNT mPSCs display, in standard conditions, a
significantly (P b 0.05) higher frequency (Figure 4, B), due to
the synaptogenic impact of MWCNTs.15 The increased number
of synapses is further supported in Figure 5, A where VGLUT1
labeled presynaptic boutons in β-tubulin III identified neuronal
bodies and dendrites, allowed to quantify VGLUT1-positive
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density in MWCNT neurons when compared to control ones.
MβCD incubation significantly (P b 0.05) increased fast mPSCs
frequency in control while in MWCNT the frequency of fast
minies was only slightly, but not significantly, reduced (plot in
Figure 4, B); to note, mPSCs amplitudes were not affected by
any treatment (box plot in Figure 4, B) indicating that the
properties of postsynaptic glutamate receptors were not altered
by these manipulations.28
These results suggest that control and MWCNTs glutamater-
gic synapses express different release machineries. Namely,
control glutamatergic synapses are dominated by spontaneous
fusions, on the contrary MWCNT ones preferentially release
neurotransmitter in response to action potentials.
To address the expression of heterogeneous populations of
presynaptic vesicles, and the different partitioning of synaptic
vesicles between the two pools, we estimate the residual activity
when PSCs were recorded prior and after the application of TTX
and Co++ (3 mM; n = 7 control and n = 7 MWCNTs). The
block of voltage-gated Ca++-channels impairs the fusion of
calcium-dependent vesicles,47 isolating the calcium-independent
“resting pool”,48 mostly involved in spontaneous neurotrans-
mission, namely the component increased by cholesterol
removal.28 In the presence of Co++ mPSCs displayed a similar
frequency in control and MWCNTs, thus the residual activity in
the presence of Ca++ channels block, in MWCNTs was
significantly smaller (P b 0.05; plots in Figure 5, B).
This different ratio suggests that synapses in control cultures
rely for their basal activity mostly on low calcium-dependent
vesicle release.25
The effects of acute cholesterol removal in control and
MWCNT hippocampal cultures at later stages of synaptic
development
Action potential evoked and spontaneous neurotransmitter
release modalities involve different molecular machineries
regulating segregated vesicle pools at the presynaptic site.
Distinct forms of neurotransmission, involving these two modes
of release, were reported to change during hippocampal synaptic
development in vitro.49 Immature synapses display high levels
of spontaneous release with respect to more mature neurons
where evoked release became particularly strong.49 Indeed, in
our experiments the acute removal of cholesterol unmasked an
opposite vesicle homeostasis across control and MWCNTs,
hinting at a tuning of synaptic maturation.49 To investigate
whether the different synaptic responses to MβCD between
control and MWCNTs were related to a transient unbalance
toward more mature release phenotype in the newly formed
MWCNT synapses, we extended our investigation to neurons in
control (n = 20) or interfaced to MWCNTs (n = 22) recorded at
18-21 DIV. In older cultures, the frequency of MWCNT PSCs
did not differ from that measured at earlier stages of development
under the same growth conditions (compare plots in Figure 2, B
and in Figure 6, A), and was similar to the value measured in
aged-matched control neurons, which conversely increased the
frequency of PSCs upon in vitro development. Figure 6, A shows
sample recordings (left) with the pooled values for PSCfrequency and amplitude summarized in the box plots (right).
The comparable control and MWCNT synaptic activity,
suggested by the similar PSC frequency, was supported by
immunofluorescence quantification of VGLUT1-positive
puncta. As shown in Figure 6, B we detected a similar density
of positive puncta between the two culture groups. Also in these
measures, MWCNT values were equal to those detected at earlier
stages of development (compare plots in Figures 5, A and 6, B),
while in control an age dependent increase in puncta was evident.
In accordance to these measures, Figure S1A shows that
frequency and amplitude of mPSCs did not differ when
comparing control and MWCNT at 18-21 DIV.
At 18-21 DIV incubating with MβCD induced a slight and
non-significant increase (Figure 6A) in the frequency of PSCs in
both cultures groups, without altering PSCs amplitudes,
suggesting that in vitro aging leads to an overall balance
between synapses expressing different release modes.49 During
the development of hippocampal neurons in culture, the levels of
membrane cholesterol usually increase50 thus we tested the
ability of MβCD incubation in depleting cholesterol in 18-21
DIV neurons. Supplemental Figure S1, B shows the reduction in
filipin fluorescence after MβCD incubation, supporting the
efficacy of such a treatment.
These results strengthen the hypothesis that MWCNTs boost
the overall network maturation, in terms of number of synapses
and efficacy,15 but in the long-term these effects reach a steady
state, probably due to the maximal connectivity homeostatically
set by the size of any given neuronal network.51
Discussion
Carbon nanotubes are increasingly incorporated in the
development of novel two-dimensional biomaterials designed
to interface tissue reconstruction and signaling.16,52 In material
science, MWCNTs are adopted in composites to strengthen
biomaterial mechanical properties, electrical conductivity or
microenvironment-defining moieties.53 However, MWCNTs are
not inert and promote synaptogenesis when interfaced to cultured
neurons.15,54 In the present study we used dissociated cultures to
investigate MWCNT ability to alter membrane lipid homeostasis
to pinpoint the earliest mechanisms that may contribute in
modulating synaptic activity. We also characterized to what
extent the MWCNTs driven synaptic enhancement is maintained
throughout long-term network development.
The principal finding of the present report is that
two-dimensional MWCNT interfaces do not alter the homeosta-
sis of membrane lipids, in particular cholesterol, in neurons. In
fact, neurons cultured interfaced to MWCNTs, display a similar
membrane cholesterol distribution and, when we used a
traditional tool to remove membrane cholesterol, MβCD,26
this treatment was as effective as in control cells. This result
differs from our preliminary observations on artificial lipid
membranes, excluding, in living neurons, a decrease mobility of
the lipid molecules via preferential interactions with the carbon
nanotubes.21 In this work we confirm the notion that MWCNT
microenvironment provide cues instructing the construction of
more synapses15,54 documented by the increase in PSCs
frequency, in mPSCs and in VGLUT1-positive labeling; the
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the higher density of glutamatergic synapses.15
The present data show that, in both culture groups, the
treatment used to remove cholesterol did not affect cell viability,
as sustained by the values of cell input resistance and membrane
capacitance.55,56 In addition, membrane micro-domains enriched
in cholesterol such as lipid rafts,57 involved in the regulation of
ionotropic glutamate receptor function,42 displayed a similar
distribution in control and MWCNT neurons when investigated
by immunofluorescence labeling and confocal microscopy58;
these structures where not altered by MβCD treatments and
indeed, in both cultures groups, miniature events' analysis
suggested the absence of major post synaptic changes due to
cholesterol removal.28
However, we found that at 8-10 DIV, release at glutamatergic
synapses in control and MWCNTs was regulated in an opposite
manner by cholesterol reduction.
To understand the reason for the observed difference, we
examined the main variable that might conceivably affect release
tuning by cholesterol. We had already excluded the possibility of
differences in membrane cholesterol distribution and depletion.
We thus turned our attention to pre-synaptic process that may be
regulated by cholesterol. Removal of cholesterol variably affects
spontaneous or evoked neurotransmitter release in cultured
neurons, improving spontaneous vesicle fusion and decreasing
evoked vesicle recycling.28
We thus hypothesized that control synapses display a higher
relative amount of spontaneous vesicle pools with respect to
MWCNT ones.
In the presence of TTX we observed that in control conditions
the frequency of mPSCs was still affected byMβCD, whereas no
changes occurred in MWCNT neurons. Our hypothesis was
further supported by the block of voltage dependent Ca++-
channels by Co++ applications.59 This condition indicated the
presence of an opposite ratio between high and low Ca++-
dependent vesicle pools in control and MWCNT presynaptic
glutamatergic terminals.
Recent reports have shown that the maturation of neurotrans-
mission is accompanied by changes in pre-synaptic release
modes; in particular spontaneous vesicle pools are predominant
on evoked ones during early stages of development, and these
two populations are gradually rebalanced during the synaptic
maturation process.49,60
It is tempting to speculate that MWCNTs accelerate synaptic
network maturation, improving synapse formation and favoring
more mature release modes, an effect that is homeostatically
regulated upon prolonged interfacing. In fact, in our experi-
ments, control and MWCNTs displayed functional and anatom-
ical similarities after three weeks of growth. We cannot
distinguish whether this was due to a progressive shielding of
the MWCNTs by extracellular matrix proteins,61 thus changing
the nano-bio interface, or rather by the homeostatic regulation of
cultured neuronal networks, constraining the maximal number of
synapses51 and their level of maturation in vitro.
In conclusion, the main finding of the present study is that
MWCNTs when used in interfacing neurons can regulate
synapse formation and function in a dynamic manner, tuning
exquisite neurobiological mechanisms, such as neuronalmaturation.62 This ability is however controlled and limited by
the physiological maturation of the synaptic circuit. This
functional integration of the MWCNTs within the newly formed
neuronal network might represent an attractive property in
designing interfaces for neuronal repair.
Brain interfaces of the future require the application of
nanomaterial-related technologies to target some of the current
ambitions in interfacing neurons: improving the stability,
flexibility and durability of the interface, improving the efficacy
of the charge transfer to and from neurons, and minimizing the
reactivity in the surrounding tissue.63 The aim is that of realizing
high resolution and minimally invasive interfaces between
recording probes and biological systems,64 able to map brain
activity and deliver precise stimuli, to interface the brain to an
external device or to facilitate recovery of function via engaging
neuronal plasticity processes,65 eventually interfacing the brain to
the spinal cord, to regain motor function after spinal cord
lesions.66 In this arena, conductive nano-materials such as carbon
nanotubes may be the adequate response to reach miniaturization
of the electrodes and neuronal-scale stimulation and recordings,
leading to an improved merging between electronic and
biosystems.67 We recently reported low tissue reaction upon
implantation in vivo of unmodified MWCNT microsystems,
suggesting a biocompatibility crucial to further design of
miniaturized platforms based on entirely new materials.17Appendix A. Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.nano.2017.01.020.References
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